A novel stereoselective synthesis of (S)-dapoxetine starting from commercially available transcinnamyl alcohol is described. Sharpless Asymmetric Epoxidation (SAE) is utilized as the key step in this synthetic strategy.
Introduction
Recently, it has been suggested that premature ejaculation (PE) might be associated with perturbations in serotonergic 5-hydroxytryptamine (5-HT) neurotransmission. 1, 2 It has been proposed that PE may be caused by decreased central serotonergic signaling, hyposensitivity of the 5-HT 2C receptor, or hypersensitivity of the 5-HT 1A receptor, all of which have been shown to decrease ejaculatory latency time in animal model systems. 3, 4 PE is a common problem, which may be associated with considerable anxiety, frustration, and negative impact on affected men and their sexual partners. No pharmaceutical agents have been approved for this indication. However, therapies that target 5-HT neurotransmission, such as selective serotonin reuptake inhibitor (SSRI) anti-depressants, have been used in this setting with varying efficacy and tolerability.
Dapoxetine is the first agent to be developed specifically to treat PE. This agent significantly prolongs IELT and increases the sense of control and sexual satisfaction for men with PE and their partners. Dapoxetine is well tolerated, with a favorable pharmacokinetic profile that allows for on-demand use. Dapoxetine hydrochloride is an SSRI with a short half-life developed specifically for the treatment of men with PE, [5] [6] [7] [8] but is slightly different from the SSRIs (such as zoloft, paxil, and prozac) ( Figure 1 ) widely prescribed for depression and other psychiatric disorders such as bulimia or anxiety. The American Urological Association as well as the International Consultation on Sexual Dysfunctions now recommends the off-label use of SSRIs, which increase 5-HT neurotransmission, for the management of PE. 1, 9, 10 Although the off-label use of antidepressant SSRIs such as fluoxetine, sertraline, and paroxetine may increase ejaculatory latency time 11-13 these SSRIs do not reach peak plasma concentrations for several hours after administration; many require a long lead-in dosing period for efficacy 1 and the typically long half-lives of these drugs can result in significant drug accumulation in the body, increased exposure to medication and, consequently, an increased likelihood of adverse events. 6, 14 In addition, men taking antidepressant SSRIs daily have reported sexual side effects such as decreased libido and erectile dysfunction after prolonged treatment with these drugs. 6 If approved by the Food and Drug Administration (FDA), this would make dapoxetine join the ranks of erectile dysfunction drugs such as sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) and some dopamine agonists such as cabergoline (Dostinex) and pramipexole, as drugs which can be used to improve male sexual health. (I) 
Results and Discussion
The Sharpless asymmetric epoxidation (SAE) can be envisioned as a powerful tool offering considerable opportunities for synthetic manipulations, 19 which has been employed as a key step in our synthetic strategy as shown in Scheme 1. We envisioned that the amino alcohol 8 could be prepared from the xanthate ester 6, which in turn could be prepared from the azido diol 3. The azido diol 3 itself could be prepared from the epoxide 2 which in turn could be synthesized by Sharpless asymmetric epoxidation of the commercially available trans-cinnamyl alcohol 1. trans-cinnamyl alcohol 1 was subjected to SAE conditions 20 to give the epoxide 2 in 88% yield with 98% ee. 21 Regioselective opening of the epoxide 2 with NaN 3 gave the azido diol 3 as the single product in 97% yield. The azido diol 3 was converted into the mono-TBS protected azido alcohol 4 in 96% yield, which on reduction with 5%Pd(C) in EtOAc followed by treatment of the amine with (Boc) 2 
Conclusions
In conclusion, a novel total synthesis of (S)-dapoxetine with high enantio-selectivity starting from a commercially available achiral starting material has been developed in which the chiral center was established by Sharpless asymmetric epoxidation to afford (S)-dapoxetine (I).
Experimental Section
General Procedures. Solvents were purified and dried by standard procedures prior to use. All the fine chemicals used were reagent grade procured commercially and used without further purification. Optical rotation was measured using sodium D line (589 nm) on a JASCO-P-1020-polarimeter under standard conditions. Infrared spectra were recorded on Perkin Elmer FT-IR spectrometer. Enantiomeric excess was measured using either the chiral HPLC ( 5 g) and Celite (500 mg) were added. After another 15 min of stirring, the mixture was allowed to settle and clean solution was filtered through a pad of Celite and washed with diethyl ether. Azeotropic removal of TBHP with toluene at a reduced pressure and subjecting the residue to high vacuum gave 2 as pale yellow oil. Recrystallization from petroleum ether/diethylether gave yellow crystals of 2 (6.89 g, 88%, 98% 'ee' determined by spectroscopic analysis of the ester derived from (+)-MTPA chloride). mp = 53. 6 
tert-Butyl (1R,2R)-3-(tert-butyldimethylsilyloxy)-2-hydroxy-1-phenylpropyl-carbamate (5).
To a solution of 4 (0.310 g, 1.008 mmol) in EtOAc (12 mL) was added (Boc) 2 O (0.242 g, 1.10 mmol), a catalytic amount of 5% Pd/C and the reaction mixture was stirred at room temperature under a hydrogen atmosphere (1 atm. balloon pressure) for 12 h. The reaction mixture was then filtered through a pad of Celite and the solvent was removed under reduced pressure to give the crude product, which was then purified by column chromatography over silica-gel using petroleum ether/EtOAc (60:40) as eluent to afford 5 as a pale yellow oil (0.338 g, 88%). was added sodium hydride (50% assay, 0.056 g, 1.17 mmol). Vigorous gas evolution was observed. After the reaction mixture was stirred for 20 min, carbon disulfide (0.100 mL, 1.64 mmol) was added in one portion. Stirring was continued for the next 30 min after which methyl iodide (0.20 mL, 3.18 mmol) was added in a single portion. The reaction mixture was stirred for another 2 h (progress of reaction mixture was monitored by TLC) and the reaction was quenched by the addition of ice-cold water (2 mL). The solution was filtered, concentrated in vacuo and the residue was extracted with ethyl acetate (3 X 5 mL). The combined organic extracts were washed with saturated sodium bicarbonate (5 mL 
